Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD Study.
Rojas Mejía DV, Zwiener RD, Cardona Villa R, Ramírez LF, Silva Espinosa DL, Zanacchi VA, Piraino Sosa P, Ensina LF, Giavina Bianchi P, Coelho Portilho N, Vivolo Aún M, Matos Benavides E, Martínez Ruíz DM, Jares E, Serrano Reyes CD. Rojas Mejía DV, et al. Among authors: serrano reyes cd. J Investig Allergol Clin Immunol. 2021 Jul 26;31(4):322-331. doi: 10.18176/jiaci.0497. Epub 2021 Feb 26. J Investig Allergol Clin Immunol. 2021. PMID: 32101172 Free article.
Drug-induced anaphylaxis, elicitors, risk factors, and management in Latin America.
Jares EJ, Cardona Villa R, Sánchez-Borges M, de Falco A, Ensina LF, Bernstein JA, Arias-Cruz A, Cherrez-Ojeda I, Morfín Maciel B, Macías-Weinmann A, González Díaz S, Sole D, Giavina-Bianchi P, de Barayazarra S, Cuello M, Vinuesa M, Calderón JC, Zanacchi VA, Monsell S, Morelo Rocha Felix M, Serrano Reyes C, Piraino P, Jaller R, Guerzet Ayres Bastos P, Gómez M; “Latin America Drug Allergy Interest Group”. Jares EJ, et al. J Allergy Clin Immunol Pract. 2020 Apr;8(4):1403-1405.e1. doi: 10.1016/j.jaip.2019.10.002. Epub 2019 Oct 15. J Allergy Clin Immunol Pract. 2020. PMID: 31626988 No abstract available.
Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.
Rojas-Mejía DV, Silva Espinosa DL, Martínez DM, Ramírez Zuluaga LF, Serrano Reyes CD. Rojas-Mejía DV, et al. Among authors: serrano reyes cd. Int Arch Allergy Immunol. 2021;182(5):433-439. doi: 10.1159/000512072. Epub 2021 Feb 16. Int Arch Allergy Immunol. 2021. PMID: 33592604
Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.
García-Gómez E, Chapman E, García-Paba MB, Ocampo-Gómez J, Egea-Bermejo E, Garavito-De Egea G, Fang L, Sarrazola M, Sánchez-Caraballo JM, Serrano-Reyes C, Silva-Espinosa DL, Rojas-Mejía DV, Moreno SM. García-Gómez E, et al. Front Allergy. 2022 May 20;3:902344. doi: 10.3389/falgy.2022.902344. eCollection 2022. Front Allergy. 2022. PMID: 35769574 Free PMC article.
Toxic epidermal necrolysis successfully treated with infliximab.
Zárate-Correa LC, Carrillo-Gómez DC, Ramírez-Escobar AF, Serrano-Reyes C. Zárate-Correa LC, et al. J Investig Allergol Clin Immunol. 2013;23(1):61-3. J Investig Allergol Clin Immunol. 2013. PMID: 23653980 Free article. No abstract available.
Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.
Fonseca DJ, Caro LA, Sierra-Díaz DC, Serrano-Reyes C, Londoño O, Suárez YC, Mateus HE, Bolívar-Salazar D, Ramírez AF, de-la-Torre A, Laissue P. Fonseca DJ, et al. Hum Genet. 2019 Dec;138(11-12):1267-1274. doi: 10.1007/s00439-019-02066-w. Epub 2019 Oct 14. Hum Genet. 2019. PMID: 31642954